RegASK is a Singapore-based RegTech SaaS platform led by CEO Caroline Shleifer that enables businesses to leverage AI to scale regulatory and compliance capabilities. The platform routinely monitors, curates and automatically summarizes regulations around the globe and provides in-depth insights into regulations and pending regulatory changes. It serves biopharma, CROs, consumer health, medical device and food companies and connects businesses with over 400 subject matter experts in 100+ countries. RegASK raised US$10M in a Series A round led by Monograph Capital with participation from SPRIM Global Investments. The company intends to use the funds to further invest in the platform and expand its business reach to bring the solution to companies seeking stronger regulatory capabilities globally. RegASK focuses on making regulatory information relevant, curated and easy to access so businesses can cut through the complexity of growing regulation. RegAsk is a Singapore-based healthcare regtech company that enables healthcare firms to manage regulatory compliance in global markets. Its AI-driven product answers regulatory questions including path-to-market, path-to-claim, product registration and regulatory strategy. The company offers a full scope of regulatory services for the food, dietary supplement, cosmetic, personal care and medical device industries. Led by president Caroline Shleifer, RegAsk intends to use the seed funding to carry out its growth strategy and advance product development. The amount raised in the seed round was not disclosed in the article. No operating metrics or past funding rounds were disclosed.

Total raised

$10M

Funding rounds

2

Latest round

Series A

Latest activity

Dec 2022